Schepens Eye Research Institute/Massachusetts Eye and Ear and the Department of Ophthalmology Harvard Medical School, Boston, Massachusetts.
Invest Ophthalmol Vis Sci. 2013 Oct 9;54(10):6612-9. doi: 10.1167/iovs.13-12861.
We have previously shown that TGF-β3 (T3) stimulates extracellular matrix (ECM) assembly while maintaining antifibrotic characteristics in a model using human corneal fibroblasts (HCFs). This model, however, requires non-physiological levels of serum. In the current study, we tested whether T3 could stimulate human corneal keratocytes (HCKs) in vitro to assemble a functional ECM, while maintaining their characteristics.
Human corneal keratocytes and HCFs were isolated and cultured using 1% or 10% serum, respectively ±T3. The constructs were processed for indirect immunofluorescence (IF), transmission electron microscopy (TEM), and qRT-PCR, analyzing for keratocyte marker, keratocan, and ECM components, collagen (col) types I, III, and V.
Quantitative reverse transcriptase PCR data showed that keratocan, col I, and V were all upregulated in HCKs compared with HCFs, whereas col III was expressed at low levels in HCKs. Transforming growth factor beta 3 stimulation further enhanced the level of change. Without T3, HCK constructs were very thin, approximately 5 μm; however, as with HCFs, upon stimulation with T3, HCK constructs increased in thickness by approximately 5-fold. Cell counts and ECM production revealed that HCKs assembled more ECM per unit area compared with HCFs, and IF revealed downregulation of fibrotic markers, col III, and thrombospondin-1, with T3 stimulation. Transmission electron microscopy data revealed aligned ECM with long fibrils for all conditions except HCK Controls. Human corneal keratocytes+T3 also showed denser collagen fibrils with more consistent fibril diameter.
Overall, the data suggests that it is possible to stimulate matrix secretion and assembly by HCKs in vitro by using a single growth factor, T3.
我们之前已经证明,TGF-β3(T3)在使用人角膜成纤维细胞(HCF)的模型中刺激细胞外基质(ECM)的组装,同时保持抗纤维化特性。然而,该模型需要非生理水平的血清。在本研究中,我们测试了 T3 是否可以刺激人角膜基质细胞(HCK)在体外组装功能性 ECM,同时保持其特性。
使用 1%或 10%血清分别分离和培养人角膜基质细胞和 HCF,±T3。处理构建体进行间接免疫荧光(IF)、透射电子显微镜(TEM)和 qRT-PCR,分析角膜细胞标志物、角膜蛋白聚糖(keratocan)和 ECM 成分,I、III 和 V 型胶原。
定量逆转录 PCR 数据显示,与 HCF 相比,HCK 中 keratocan、col I 和 V 均上调,而 col III 在 HCK 中表达水平较低。TGF-β3 刺激进一步增强了变化水平。没有 T3,HCK 构建体非常薄,约 5μm;然而,与 HCF 一样,用 T3 刺激后,HCK 构建体的厚度增加了约 5 倍。细胞计数和 ECM 产生表明,与 HCF 相比,HCK 组装的 ECM 更多,IF 显示 T3 刺激下纤维化标志物 col III 和血栓素-1 下调。透射电子显微镜数据显示,除 HCK 对照外,所有条件下的 ECM 均排列整齐,有长纤维。T3 刺激的 HCK+T3 还显示出更密集的胶原纤维,纤维直径更一致。
总体而言,数据表明,通过使用单一生长因子 T3,体外刺激 HCK 分泌和组装基质是可行的。